LYRA:US
$0.112
-0.975%
Lyra Therapeutics Inc.Insider Activity
Last updated: May 18, 2025, 9:05 AM ET
Profile
Company Description
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration.